Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||
| Net Income | -8,278 | -26,730 | N/A |
| Depreciation Amortization | 313 | 220 | N/A |
| Accounts receivable | 478 | N/A | N/A |
| Other Working Capital | 332 | 230 | N/A |
| Other Operating Activity | -406 | 19,550 | 0 |
| Operating Cash Flow | $-7,561 | $-6,730 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -135 | -110 | N/A |
| Net Acquisitions | -72 | -2,200 | N/A |
| Purchase Sale Intangibles | -283 | N/A | N/A |
| Other Investing Activity | -283 | -260 | 0 |
| Investing Cash Flow | $-490 | $-2,570 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 8,225 | N/A | N/A |
| Other Financing Activity | 0 | 180 | 0 |
| Financing Cash Flow | $8,225 | $180 | $N/A |
| Beginning Cash Position | 8,510 | 17,630 | N/A |
| End Cash Position | 8,683 | 8,510 | N/A |
| Net Cash Flow | $173 | $-9,120 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -7,561 | -6,730 | N/A |
| Capital Expenditure | -135 | N/A | N/A |
| Free Cash Flow | -7,697 | -6,730 | 0 |